Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma

BACKGROUND: To investigate the relationship between hematologic test results and the predictive effect of regression of esophageal cancer after neoadjuvant chemotherapy (NACT), we analyzed pre-NACT hematologic data and their relationship to tumor regression. METHODS: Thirty-eight consecutive patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yinan, Chen, Jinfeng, Shao, Ningsheng, Feng, Yuan, Wang, Yuzhao, Zhang, Lijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938076/
https://www.ncbi.nlm.nih.gov/pubmed/24568553
http://dx.doi.org/10.1186/1477-7819-12-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938076/
https://www.ncbi.nlm.nih.gov/pubmed/24568553
http://dx.doi.org/10.1186/1477-7819-12-43

Ejemplares similares